日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Ligand-activated EGFR/MAPK signaling but not PI3K, are key resistance mechanisms to EGFR-therapy in colorectal cancer.

配体激活的 EGFR/MAPK 信号通路（而非 PI3K）是结直肠癌中 EGFR 疗法产生耐药性的关键机制

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-59588-3
Qu Xueping, Hamidi Habib, Johnson Radia M, Sokol Ethan S, Lin Eva, Eng Cathy, Kim Tae Won, Bendell Johanna, Sivakumar Smruthy, Kaplan Benjamin, de Sousa E Melo Felipe, Mancini Andrew, Wongchenko Matthew, Shi Yi, Shames David, Yan Yibing, Ciardiello Fortunato, Bais Carlos
肿瘤
肠癌
EGFR
发表日期：2025
文献求助 收藏

Transcriptomic profiling of adjuvant colorectal cancer identifies three key prognostic biological processes and a disease specific role for granzyme B

辅助性结直肠癌的转录组分析揭示了三个关键的预后生物学过程以及颗粒酶B在疾病特异性中的作用

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0262198
Daemen, Anneleen; Udyavar, Akshata R; Sandmann, Thomas; Li, Congfen; Bosch, Linda J W; O'Gorman, William; Li, Yijin; Au-Yeung, Amelia; Takahashi, Chikara; Kabbarah, Omar; Bourgon, Richard; Hegde, Priti; Bais, Carlos; Das Thakur, Meghna
肿瘤
肠癌
肿瘤免疫
发表日期：2021
文献求助 收藏

Development of a gene expression-based prognostic signature for IDH wild-type glioblastoma

构建基于基因表达的IDH野生型胶质母细胞瘤预后特征

期刊:Neuro-Oncology
影响因子:13.4
doi:10.1093/neuonc/noaa157
Johnson, Radia M; Phillips, Heidi S; Bais, Carlos; Brennan, Cameron W; Cloughesy, Timothy F; Daemen, Anneleen; Herrlinger, Ulrich; Jenkins, Robert B; Lai, Albert; Mancao, Christoph; Weller, Michael; Wick, Wolfgang; Bourgon, Richard; Garcia, Josep
细胞生物学
发表日期：2020
文献求助 收藏

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer

贝伐珠单抗一线治疗卵巢癌随机试验的最终总生存期

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.19.01009
Tewari, Krishnansu S; Burger, Robert A; Enserro, Danielle; Norquist, Barbara M; Swisher, Elizabeth M; Brady, Mark F; Bookman, Michael A; Fleming, Gini F; Huang, Helen; Homesley, Howard D; Fowler, Jeffrey M; Greer, Benjamin E; Boente, Matthew; Liang, Sharon X; Ye, Chenglin; Bais, Carlos; Randall, Leslie M; Chan, John K; Ferriss, J Stuart; Coleman, Robert L; Aghajanian, Carol; Herzog, Thomas J; DiSaia, Philip J; Copeland, Larry J; Mannel, Robert S; Birrer, Michael J; Monk, Bradley J
肿瘤
肿瘤免疫
卵巢癌
发表日期：2019
文献求助 收藏

Tumor Microvessel Density as a Potential Predictive Marker for Bevacizumab Benefit: GOG-0218 Biomarker Analyses

肿瘤微血管密度作为贝伐单抗疗效的潜在预测标志物：GOG-0218 生物标志物分析

期刊:Jnci-Journal of the National Cancer Institute
影响因子:7.2
doi:10.1093/jnci/djx066
Bais, Carlos; Mueller, Barbara; Brady, Mark F; Mannel, Robert S; Burger, Robert A; Wei, Wei; Marien, Koen M; Kockx, Mark M; Husain, Amreen; Birrer, Michael J
肿瘤
肿瘤免疫
发表日期：2017
文献求助 收藏

Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial

贝伐珠单抗联合一线放疗和替莫唑胺治疗可能使原神经胶质母细胞瘤患者获得总生存获益：AVAglio试验的回顾性分析

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2015.61.5005
Sandmann, Thomas; Bourgon, Richard; Garcia, Josep; Li, Congfen; Cloughesy, Timothy; Chinot, Olivier L; Wick, Wolfgang; Nishikawa, Ryo; Mason, Warren; Henriksson, Roger; Saran, Frank; Lai, Albert; Moore, Nicola; Kharbanda, Samir; Peale, Franklin; Hegde, Priti; Abrey, Lauren E; Phillips, Heidi S; Bais, Carlos
细胞生物学
神经科学
发表日期：2015
文献求助 收藏